Friday’s close split three ways. The Dow Jones Industrial Average rose 235.60 points, or 0.46%, to 51,947.25. The S&P 500 added 0.05% to finish at 7,411.98 — flat to the naked eye. The Nasdaq Composite dropped 0.64% to 24,975.82. Three indexes, one market, two directions.
The wreckage was all in one place. Intel fell nearly 8% — the day after reporting revenue of $16.1 billion against a roughly $14.3 billion consensus, earnings of $0.42 a share against $0.21 expected, and 25% year-over-year sales growth, its best stretch in almost fifteen years. Micron dropped 7%. AMD fell 3.3%. Broadcom fell 2.7%. The VanEck Semiconductor ETF gave up 3%. Meanwhile Apple rose 3.5% and did most of the work lifting the Dow.
That is not a market losing its nerve. A market losing its nerve sells everything. This market sold one specific thing: companies writing enormous checks to build AI capacity. It happened Thursday, when the Magnificent Seven shed roughly $797 billion in market value in a single session — the group’s worst day since April 2025 — after Alphabet guided capital spending toward $205 billion and Tesla flagged its own build-out. It happened again Friday to Intel, which beat on every line that used to matter and got sold on the line that now does.
Our take: For three years, announcing a bigger AI capex number was the cheapest way to add market cap. The number itself was the news; the return on it was somebody else’s problem, later. This week the market started pricing capex as what it actually is on the balance sheet — cash out the door against revenue that hasn’t shown up yet. Nothing about the AI buildout got worse. What changed is that investors began asking to be paid for financing it, and that repricing hits the spenders first. Note who led the Dow higher: the megacap doing the least concrete-pouring.
The week, not the day
Friday’s divergence is easier to read across five sessions. The Nasdaq lost 2.1% on the week and the S&P 500 lost 0.6% — both back-to-back weekly declines. The Dow lost 0.4%, its third straight losing week. The blue chips have been bleeding longer and slower; the tech complex took its damage in two concentrated days tied to earnings and capital plans.
The rest of Friday’s tape was constructive, which is exactly why the chip selling stands out. Brent crude fell about 4% to trade below $96 after touching $100 earlier in the week, on reports of a possible path back to US–Iran talks — a straightforward removal of an inflation risk. S&P Global’s flash PMI showed US business activity expanding at its fastest pace in eight months. Safety Insurance jumped 42% on a $1.54 billion all-cash agreement to be acquired by Mapfre at $105 a share, a 44% premium. Amkor rose 9%. CSX rose 6% on an earnings beat and better volumes. Money was not hiding. It was moving.
What to watch
- Whether beats keep getting punished. Intel is the cleanest test case yet: strong quarter, strong guide, stock down 8%. If that repeats through the rest of earnings season, the market has changed its scoring system rather than just had a bad week.
- Capex guidance language. Watch for management teams framing spending with a return figure attached instead of a raw dollar total. That shift, when it comes, is the tell that companies have noticed.
- Suppliers versus spenders. If capex risk is being repriced, the picks-and-shovels names eventually feel it too — their order books are the spenders’ budgets. Friday they did: AMD fell even after launching its Helios rack. Watch whether that holds.
- Oil, still. Sub-$96 Brent takes pressure off the inflation path and the long end. Back above $100 and the bond market re-enters the conversation, and none of the above matters as much.
The market did not decide this week that AI is a bad bet. It decided it wants to see the invoice. Those are very different conclusions, and only one of them is bearish — but the second one still costs the spenders a lot of market cap on the way through.